2014 Archived Content

Cambridge Healthtech Institute's Third Annual
Point-of-Care Diagnostics
Enabling Personalized Healthcare Through Rapid Diagnostics
Part of the 21st Annual Molecular Medicine Tri-Conference

February 13-14, 2014 | Westin St. Francis | San Francisco, CA

Day 1 | Day 2 | Symposia Brochure | Full Event Brochure    

Friday, February 14

8:00 am Morning Coffee


8:25 Chairperson’s Remarks

Peter Miller, COO, Genomic Healthcare Strategies

8:30 Strategic Growth Initiatives, Alliances, and Innovation in Molecular Diagnostics at the Point-of-Care

Michael Nohaile, Ph.D., Vice President, Corporate Strategy, Amgen, Inc.

9:00 Building an Innovative Team: The Key to Success

Craig Lehmann, Ph.D., CC (NRCC), FACB, Dean, The School of Health Technology and Management; Professor, Clinical Laboratory Sciences; Director, Center of Public Health Education, School of Health Technology Management, Stony Brook University

Under the spirit of innovation this presentation is to address opportunities of the many needs of the world’s priorities to deliver high impact interventions that will improve health outcomes for their citizens while strengthening health systems.


9:30 The Changing Landscape in Point-of-Care Diagnostics: Advances in Developing World Applications and Their Potential Impact in Developed Markets

Rich Thayer, Managing Partner, Halteres Associates, LLC; CEO, Catalysis Foundation for Health

Understanding unmet needs and business model options prior to initiating development of POC systems for limited resource settings is essential for success. Learn how advancements in diagnostics technologies and communications, in addition to a better understanding of local market conditions and needs, are driving increased interest in delivering diagnostic solutions for these important markets.


10:00 Microfluidics for Mobile Diagnostics

Samuel K. Sia, Associate Professor, Biomedical Engineering, Columbia University

Lab-on-a-chip (LOC) devices have a tremendous potential for revolutionizing personal health. In developing countries, mobile diagnostics provides immediate diagnosis in the field, and in the U.S., patients and consumers can have greater access to traditionally complex diagnostics. We will discuss our lab’s current efforts in these areas, in conjunction with partners in industry, public health, and local governments. Our tests span a variety of technologies, and target HIV, sexually-transmitted diseases, and chronic diseases.

10:30 Coffee Break with Exhibit and Poster Viewing


10:55 Chairperson's Remarks

Michael Nohaile, Ph.D., Vice President, Corporate Strategy, Amgen, Inc.

11:05 The HemoLink: Enabling POC Blood Sampling, Stabilization, Preparation, and Remote Analysis

Erwin Berthier, President, Tasso, Inc.

HIV viral load monitoring is a critical test for HIV management that requires large volumes of blood (>100 uL) and forpatients to locate to an appropriately equipped laboratory or clinic. Tasso has developed the HemoLink to connect patients at home by allowing self-administered blood sampling with the laboratory for remote analysis. The next-generation platform integrates novel technology enabling on-site RNA purification - a step towards POC viral load monitoring.

11:30 Transforming Alzheimer’s Diagnosis

Elli Kaplan, CEO, Neurotrack

Neurotrack’s technology can predict the onset of Alzheimer’s disease three to six years before symptoms occur. Based on groundbreaking research, Neurotrack’s technology will enable pharmaceutical companies and CROs to recruit optimal candidates for clinical trials and more effectively measure drug efficacy, speeding up drug development.

11:45 Kinsa Smart Thermometer: Real-Time Health Mapping

Inder Singh, Founder & CEO, Kinsa Health

Kinsa is creating a real-time map of human health, beginning with contagious illness. Using data from mobile-enabled health products, this map will give parents better information as well as help physicians better diagnose and care for patients. The Kinsa Smart Thermometer is a mobile-connected thermometer that allows us to communicate with someone who has just fallen ill, give them the information to get better faster, and collect the data we need to map human health.

12:00 pm Handheld Smartphone Biosensing

Kenny Long, University of Urbana-Champaign

We present a smartphone system based on a custom optical cradle as a spectrometric instrument capable of detecting clinically relevant concentrations of biological analytes using different assay techniques. By translating existing diagnostic tests to a portable system, we open the doors for new applications of proven technologies.

12:15 Ultrasensitive POCT on a Nonfouling Polymer Brush

Ashutosh Chilkoti, Ph.D., Theo Pilkington Chair in Biomedical Engineering; Director, Center for Biologically Inspired Materials and Materials Systems, Duke University

We have developed a POCT in which all reagents are inkjet printed on a polymer brush and which relies upon passive, 2-D diffusion across the brush to generate a colorimetric signal. This assay works with all sandwich immunoassay formats, is quantitative, multiplexable, with sub-picomolar limit-of-detection.

12:30 Close of Symposium

Day 1 | Day 2 | Symposia Brochure | Full Event Brochure    

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors

Beckman Coulter Life Sciences 

Boston Healthcare



Charles River no tagline


Cofactor Genonics


Menarini Silicon Biosystems






View All Sponsors